We all know the ramifications of smoking every day or a diet that’s a result of grocery shopping from a drive-thru. But, what ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
Generally, he added, the best value you’ll find are creams, and he’s a fan of Dollar Tree’s CareAll brand arthritis and ...
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Content oversight and quality assurance provided by Norcal Community Media. Norcal Community Media advertising leadership ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
(Bloomberg) -- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies ...
LONDON, United Kingdom - AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with ...
LONDON, Nov 4 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday its experimental weight-loss pill, licensed a year ago from China's Eccogene for up to $2 billion, was safe and ...
The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.